Spironolactone and risk of upper gastrointestinal events: Causality remains unconvincing [10]

British Medical Journal

Volumn 333, Issue 7566, 2006, Pages 501-

  Jones, Gruffydd P ^a  

^a Meddygfa Waunfawr   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTICOAGULANT AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; SPIRONOLACTONE; ALDOSTERONE ANTAGONIST;

GASTROINTESTINAL HEMORRHAGE; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; CHEMICALLY INDUCED DISORDER; NOTE;

ALDOSTERONE ANTAGONISTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; RISK FACTORS; SPIRONOLACTONE;

EID: 33748423102     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7566.501-a     Document Type: Letter

References (1)

1. Verhamme K, Mosis G, Dieleman J, Stricker B, Sturkenboom M. Spironolactone and risk of upper gastrointestinal events: population based case-control study. BMJ 2006;333:330-3.